Altered proportions of naïve, central memory and terminally differentiated central memory subsets among CD4 + and CD8 + T cells expressing CD26 in patients with type 1 diabetes

Journal of Clinical Immunology

Volumn 31, Issue 6, 2011, Pages 977-984

  Matteucci, Elena ^a   Ghimenti, Massimo ^a   Di Beo, Serena ^a   Giampietro, Ottavio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

CCR7; CD26; CD45RA; Lymphocyte subsets; Type 1 diabetes

Indexed keywords

CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; DIPEPTIDYL PEPTIDASE IV; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL MEMORY T LYMPHOCYTE; CONTROLLED STUDY; DISEASE DURATION; EFFECTOR MEMORY T LYMPHOCYTE; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TERMINALLY DIFFERENTIATED CENTRAL MEMORY T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIPEPTIDYL PEPTIDASE 4; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INFANT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, CCR7; T-LYMPHOCYTE SUBSETS;

EID: 84857059169     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9573-z     Document Type: Article

References (32)

1. Ohnuma K, Dang NH, Morimoto C. Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol. 2008;29:295-301.
2. Matteucci E, Giampietro O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem. 2009;16:2943-51.
3. Martinez-Navio JM, Casanova V, Pacheco R, Naval-Macabuhay I, Climent N, Garcia F, et al. Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells. J Leukoc Biol. 2011;89:127-36.
4. Liu Z, Christensson M, Forslöw A, De Meester I, Sundqvist KG. A CD26-controlled cell surface cascade for regulation of T cell motility and chemokine signals. J Immunol. 2009;183:3616-24.
5. Klemann C, Schade J, Pabst R, Leitner S, Stiller J, von Hörsten S, et al. CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukocyte subsets in F344-rats age-dependently. Clin Exp Immunol. 2009;155:357-65.
6. Tian L, Gao J, Hao J, Zhang Y, Yi H, O'Brien TD, et al. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor. Endocrinology. 2010;151:3049-60.
7. Kim SJ, Nian C, Doudet DJ, McIntosh CH. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation. Diabetes. 2009;58:641-51.
8. Ibegbu CC, Xu YX, Fillos D, Radziewicz H, Grakoui A, Kourtis AP. Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection. Immunology. 2009;126:346-53.
9. Matteucci E, Ghimenti M, Consani C, Di Beo S, Giampietro O. About CD26 CD8 lymphocytes in type 1 diabetes mellitus. Scand J Immunol. 2010;71:123-4.
10. Monti P, Heninger AK, Bonifacio E. Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus. Curr Diab Rep. 2009;9:113-8.
11. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745-63. (Pubitemid 38680440)
12. Pearce EL. Metabolism of T cell activation and differentiation. Curr Opin Immunol. 2010;22:314-20.
13. Viglietta V, Kent SC, Orban T, Hafler DA. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest. 2002;109:895-903. (Pubitemid 34275110)
14. Hofer J, Hofer S, Zlamy M, Jeller V, Koppelstaetter C, Brandstätter A, et al. Elevated proportions of recent thymic emigrants in children and adolescents with type 1 diabetes. Rejuvenation Res. 2009;12:311-20.
15. Mikulkova Z, Praksova P, Stourac P, Bednarik J, Strajtova L, Pacasova R, et al. Numerical defects in CD8+CD28-T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis. Cell Immunol. 2010;262:75-9.
16. Hedman M, Faresjö M, Axelsson S, Ludvigsson J, Casas R. Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children. Clin Exp Immunol. 2008;153:360-8.
17. Bell EB, Westermann J. CD4 memory T cells on trial: immuno-logical memory without a memory T cell. Trends Immunol. 2008;29:405-11.
18. Macallan DC, Wallace D, Zhang Y, De Lara C, Worth AT, Ghattas H, et al. Rapid turnover of effector-memory CD4(+) T cells in healthy humans. J Exp Med. 2004;200:255-60. (Pubitemid 38982184)
19. Gerlach C, van Heijst JW, Schumacher TN. The descent of memory T cells. Ann N Y Acad Sci. 2011;1217:139-53.
20. Geginat J, Lanzavecchia A, Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood. 2003;101:4260-6. (Pubitemid 36857786)
21. Harari A, Enders FB, Cellerai C, Bart PA, Pantaleo G. Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J Virol. 2009;83:2862-71.
22. Dunne PJ, Belaramani L, Fletcher JM, Fernandez de Mattos S, Lawrenz M, Soares MV, et al. Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection. Blood. 2005;106:558-65. (Pubitemid 40981251)
23. Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing. 2008;5:6.
24. Harari A, Vallelian F, Pantaleo G. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur J Immunol. 2004;34:3525-33. (Pubitemid 40012170)
25. Appay V, van Lier RA, Sallusto F, Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A. 2008;73:975-83.
26. Ilonen J, Surcel HM, Käär ML. Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes. Clin Exp Immunol. 1991;85:278-81.
27. Smerdon RA, Peakman M, Hussain MJ, Alviggi L, Watkins PJ, Leslie RD, et al. Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes. 1993;42:127-33. (Pubitemid 23013804)
28. Rowe PA, Campbell-Thompson ML, Schatz DA, Atkinson MA. The pancreas in human type 1 diabetes. Semin Immunopathol. 2011;33:29-43.
29. Ramakrishnan P, Kahn DA, Baltimore D. Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cells. Cell Death Differ. 2010;18:690-9. doi:10.1038/cdd.2010.163.
30. Kowluru RA, Chan PS. Metabolic memory in diabetes-from in vitro oddity to in vivo problem: role of apoptosis. Brain Res Bull. 2010;81:297-302.
31. Gu N, Tsuda M, Matsunaga T, Adachi T, Yasuda K, Ishihara A, et al. Glucose regulation of dipeptidyl peptidase IV gene expression is mediated by hepatocyte nuclear factor-1alpha in epithelial intestinal cells. Clin Exp Pharmacol Physiol. 2008;35:1433-9.
32. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009;94:3171-82.